0

542918

GIANLIFE

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

Gian Life Care Limited Share Price Today

Investment Returns

Over 1 Month -12.39% Over 3 Months -27.39% Over 6 Months -40.38% Over 1 Year -67.22%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

Gian Life Care Limited fundamentals


  • Market cap (Cr) [-]
  • P/E Ratio (TTM) [-]
  • Beta [-]
  • Book Value / share [-]
  • Return on equity [-]%
  • EPS (TTM) [-]
  • Dividend yield [-]%
  • Net profit/quarter (Cr) [-]
info icon alternate text
  • Market cap (Cr) 5.50
  • P/E Ratio (TTM) -7.16
  • Beta 0.09
  • Book Value / share 18.71
  • Return on equity 0.81%
  • EPS (TTM) 0.00
  • Dividend yield [-]%
  • Net profit/quarter (Cr) 0.12
info icon alternate text

Gian Life Care Limited Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition
info-icon
Revenue
Net income
Particulars DEC 2025 (Values in Cr)
Revenue 1.12
Operating Expense 1.10
Net Profit 0.12
Net Profit Margin (%) 10.71
Earnings Per Share (EPS) 0.12
EBITDA 0.34
Effective Tax Rate (%) -30.00
Particulars SEP 2025 (Values in Cr)
Revenue 0.66
Operating Expense 1.25
Net Profit -0.46
Net Profit Margin (%) -69.69
Earnings Per Share (EPS) -0.45
EBITDA -0.30
Effective Tax Rate (%) 8.00
Particulars JUN 2025 (Values in Cr)
Revenue 0.87
Operating Expense 0.92
Net Profit 0.05
Net Profit Margin (%) 5.74
Earnings Per Share (EPS) 0.05
EBITDA 0.27
Effective Tax Rate (%) 37.50
Particulars MAR 2025 (Values in Cr)
Revenue 1.11
Operating Expense 1.32
Net Profit -0.48
Net Profit Margin (%) -43.24
Earnings Per Share (EPS) -0.47
EBITDA -0.25
Effective Tax Rate (%) -4.34
Particulars DEC 2024 (Values in Cr)
Revenue 1.59
Operating Expense 1.33
Net Profit 0.38
Net Profit Margin (%) 23.89
Earnings Per Share (EPS) 0.37
EBITDA 0.64
Effective Tax Rate (%) 9.52
Particulars MAR 2025 (Values in Cr)
Revenue 6.63
Operating Expense 6.58
Net Profit 0.16
Net Profit Margin (%) 2.41
Earnings Per Share (EPS) 0.14
EBITDA 1.18
Effective Tax Rate (%) 46.66
Particulars MAR 2024 (Values in Cr)
Revenue 13.12
Operating Expense 7.85
Net Profit 4.30
Net Profit Margin (%) 32.77
Earnings Per Share (EPS) 4.16
EBITDA 6.82
Effective Tax Rate (%) 27.41
Particulars MAR 2023 (Values in Cr)
Revenue 11.92
Operating Expense 10.84
Net Profit 1.26
Net Profit Margin (%) 10.57
Earnings Per Share (EPS) 1.22
EBITDA 2.72
Effective Tax Rate (%) 29.60
Particulars MAR 2022 (Values in Cr)
Revenue 15.93
Operating Expense 10.58
Net Profit 4.37
Net Profit Margin (%) 27.43
Earnings Per Share (EPS) 4.23
EBITDA 6.52
Effective Tax Rate (%) 25.29
Particulars MAR 2021 (Values in Cr)
Revenue 10.46
Operating Expense 7.99
Net Profit 2.02
Net Profit Margin (%) 19.31
Earnings Per Share (EPS) 4.29
EBITDA 3.34
Effective Tax Rate (%) 26.90
Particulars MAR 2025 (Values in Cr)
Book Value / Share 18.60
ROE % -0.21
ROCE % 2.31
Total Debt to Total Equity 0.28
EBITDA Margin 18.40
Particulars MAR 2024 (Values in Cr)
Book Value / Share 18.64
ROE % 24.13
ROCE % 27.80
Total Debt to Total Equity 0.27
EBITDA Margin 51.98
Particulars MAR 2023 (Values in Cr)
Book Value / Share 14.62
ROE % 7.27
ROCE % 11.22
Total Debt to Total Equity 0.23
EBITDA Margin 21.31
Particulars MAR 2022 (Values in Cr)
Book Value / Share 13.56
ROE % 31.15
ROCE % 38.66
Total Debt to Total Equity 0.14
EBITDA Margin 41.24
Particulars MAR 2025 (Values in Cr)
Book Value / Share 19.11
ROE % 0.81
ROCE % 2.90
Total Debt to Total Equity 0.23
EBITDA Margin 18.10
Particulars MAR 2024 (Values in Cr)
Book Value / Share 18.97
ROE % 24.63
ROCE % 28.36
Total Debt to Total Equity 0.25
EBITDA Margin 52.13
Particulars MAR 2023 (Values in Cr)
Book Value / Share 14.81
ROE % 8.59
ROCE % 12.25
Total Debt to Total Equity 0.23
EBITDA Margin 22.90
Particulars MAR 2022 (Values in Cr)
Book Value / Share 13.57
ROE % 36.89
ROCE % 46.55
Total Debt to Total Equity 0.13
EBITDA Margin 41.24
Particulars MAR 2021 (Values in Cr)
Book Value / Share 20.54
ROE % 23.35
ROCE % 32.06
Total Debt to Total Equity 0.12
EBITDA Margin 32.41
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 6.95
Total Assets 35.93
Total Liabilities 35.93
Total Equity 19.23
Share Outstanding 1
Price to Book Ratio 0.90
Return on Assets (%) -0.10
Return on Capital (%) -0.15
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 5.98
Total Assets 32.63
Total Liabilities 32.63
Total Equity 19.27
Share Outstanding 1
Price to Book Ratio 1.29
Return on Assets (%) 12.72
Return on Capital (%) 17.19
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 5.76
Total Assets 28.24
Total Liabilities 28.24
Total Equity 15.11
Share Outstanding 1
Price to Book Ratio 1.15
Return on Assets (%) 3.76
Return on Capital (%) 5.4
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 4.85
Total Assets 23.06
Total Liabilities 23.06
Total Equity 14.02
Share Outstanding 1
Price to Book Ratio 3.06
Return on Assets (%) 18.95
Return on Capital (%) 27.5
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 6.94
Total Assets 35.55
Total Liabilities 35.55
Total Equity 19.76
Share Outstanding 1
Price to Book Ratio 0.90
Return on Assets (%) 0.43
Return on Capital (%) 0.63
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 5.97
Total Assets 32.07
Total Liabilities 32.07
Total Equity 19.61
Share Outstanding 1
Price to Book Ratio 1.29
Return on Assets (%) 13.39
Return on Capital (%) 18.06
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 5.75
Total Assets 28.40
Total Liabilities 28.40
Total Equity 15.31
Share Outstanding 1
Price to Book Ratio 1.15
Return on Assets (%) 4.42
Return on Capital (%) 6.32
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 4.74
Total Assets 23.05
Total Liabilities 23.05
Total Equity 14.03
Share Outstanding 1
Price to Book Ratio 3.06
Return on Assets (%) 18.97
Return on Capital (%) 27.51
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 2.51
Total Assets 15.47
Total Liabilities 15.47
Total Equity 9.65
Share Outstanding 0
Price to Book Ratio 0.66
Return on Assets (%) 13.03
Return on Capital (%) 19.53
Particulars MAR 2025 (Values in Cr)
Net Income 0.03
Cash from Operations 0.29
Cash from Investing 0.25
Cash from Financing 0.45
Net change in Cash 0.97
Free Cash Flow 0.30
Particulars MAR 2024 (Values in Cr)
Net Income 5.74
Cash from Operations 0.71
Cash from Investing -0.31
Cash from Financing -0.16
Net change in Cash 0.22
Free Cash Flow 1.69
Particulars MAR 2023 (Values in Cr)
Net Income 1.59
Cash from Operations 2.24
Cash from Investing -0.94
Cash from Financing -0.36
Net change in Cash 0.91
Free Cash Flow 3.87
Particulars MAR 2022 (Values in Cr)
Net Income 5.84
Cash from Operations 6.46
Cash from Investing -4.12
Cash from Financing 0.67
Net change in Cash 2.34
Free Cash Flow 7.42
Particulars MAR 2025 (Values in Cr)
Net Income 0.29
Cash from Operations 0.27
Cash from Investing 0.23
Cash from Financing 0.48
Net change in Cash 0.97
Free Cash Flow 0.28
Particulars MAR 2024 (Values in Cr)
Net Income 5.91
Cash from Operations 0.76
Cash from Investing 0.32
Cash from Financing -0.85
Net change in Cash 0.22
Free Cash Flow 1.07
Particulars MAR 2023 (Values in Cr)
Net Income 1.78
Cash from Operations 2.33
Cash from Investing -0.94
Cash from Financing -0.36
Net change in Cash 1.00
Free Cash Flow 3.97
Particulars MAR 2022 (Values in Cr)
Net Income 5.85
Cash from Operations 6.46
Cash from Investing -4.23
Cash from Financing 0.67
Net change in Cash 2.23
Free Cash Flow 7.42
Particulars MAR 2021 (Values in Cr)
Net Income 2.75
Cash from Operations 3.16
Cash from Investing -1.09
Cash from Financing -0.38
Net change in Cash 1.38
Free Cash Flow 3.59
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
APOLLO HOSPITALS ENTERPRISE LT 8467.10 62.24 12.85 121743.91 6680.00 8624.20
FORTIS MALAR HOSPITALS LIMITED 53.15 24.05 2.90 99.61 40.75 77.00
SHREE PACETRONIX LTD. 141.50 16.89 2.97 53.06 66.10 283.15
TRANSGENE BIOTEK LTD. 2.90 0.00 2.62 21.97 1.83 5.26
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
APOLLO HOSPITALS ENTERPRISE LT 8467.10 81.09 12.21 121743.91 6680.00 8624.20
[-] 0.0 0.0 0.0 0.0 0.0 0.0
CHENNAI MEENAKSHI MULTISPECIAL 35.88 0.00 -8.73 26.80 30.30 57.48
KOVAI MEDICAL CENTER & HO 5770.70 25.82 4.78 6313.15 5010.00 6725.00

Gian Life Care Limited shareholding pattern

Holding
69.83%
30.16%
65.08%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

Gian Life Care Limited Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
5.32 0.37 redarrow
red-green-graph indicator
16 Bearish
0 Bullish
  • 5 Days 5.50
  • 26 Days 5.90
  • 10 Days 5.60
  • 50 Days 6.30
  • 12 Days 5.70
  • 100 Days 7.30
  • 20 Days 5.80
  • 200 Days 9.50
5.33 PIVOT
First Support 5.08 First Resistance 5.56 Second Support 4.85 Second Resistance 5.81 Third Support 4.60 Third Resistance 6.04
RSI 33.26 ADX 17.15 MACD -0.20 Williams % R -82.41 Commodity Channel Index (CCI) -194.43
Date 2026-06-15 Week 14709.00 Same Day 22406.00 Month 12774.00
1 Year 0.09 3 Year 0.33
Over 1 Month
-12.39% down
Over 1 Year
-67.22% down
Over 3 Months
-27.39% down
Over 3 Years
-36.50% down
Over 6 Months
-40.38% down
Over 5 Years
-15.14% down

Gian Life Care Limited Corporate Actions

Ex-Date Ex-Bonus Ratio
30 Mar 2022 29 Mar 2022 6:5

Top Gainers

Top Losers

stock
Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Gian Lifecare Ltd?

Answer Field

Gian Lifecare Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 5.32 as on Jun 16 2026 12:00 AM.

What is the Market Cap of Gian Lifecare Ltd Share?

Answer Field

The market cap of Gian Lifecare Ltd for NSE ₹ 0.00 & for BSE ₹ 5.50 as on Jun 16 2026 12:00 AM.

What is the 52 Week High and Low of Gian Lifecare Ltd?

Answer Field

The 52 Week High and Low of Gian Lifecare Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 17.49 and ₹ 5.04.

What is 1 year return for Gian Lifecare Ltd?

Answer Field

The 1 year returns on the stock has been -67.22%.

What is the P/E Ratio of Gian Lifecare Ltd Share?

Answer Field

As on Jun 16 2026 12:00 AM the price-to-earnings (PE) ratio for Gian Lifecare Ltd share is -7.16.

What is the PB ratio of Gian Lifecare Ltd Share?

Answer Field

As on Jun 16 2026 12:00 AM, the price-to-book (PB) ratio for Gian Lifecare Ltd share is 18.71.

How to Buy Gian Lifecare Ltd Share?

Answer Field

You can trade in Gian Lifecare Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Gian Lifecare Ltd Share on Bajaj Broking App?

Answer Field

To buy Gian Lifecare Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Gian Lifecare Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image
Get Free Demat Account*
+91
close-img
Authorise with OTP
Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|